Emergent to lay off 400 staffers, eliminate executive position in pivot away from contract manufacturing

Big changes are brewing at Emergent BioSolutions, as the beleaguered contract manufacturer puts its CDMO business on the back burner in a bid to shore up its core medical countermeasures and Narcan businesses.